BMJ 2000;321:311-312 ( 5 August )

Editorials

Improving the treatment of tobacco dependence

Simple messages and an infrastructure to deliver them are needed

Papers pp 323, 329 Clinical review p 355

The first 150 words of the full text of this article appear below.

Efforts to treat tobacco dependence are meant to supplement rather than to replace attempts to stop the tobacco industry's predatory recruitment of new smokers. Over 1.2 billion people worldwide regularly smoke tobacco products,¹ not including the use of roll-your-owns or smokeless tobacco. Reductions in numbers of deaths caused by tobacco over the next 50 years will depend largely on the success of tobacco users in breaking or controlling their addiction. Only in the second half of this century will our progress, such as it is, towards reducing the uptake of smoking among young people manifestly affect mortality.²

Three articles in this issue show the importance of smoking cessation or discuss the growing repertoire of effective pharmacological and behavioural approaches for treating nicotine dependence.^2-4 Their publication coincides with the 11th world conference on tobacco or health, which will focus on treatment issues such as quality, availability, and affordability.

There are some simple messages . . . [Full text of this article]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Articles

Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies

Richard Peto, Sarah Darby, Harz Deo, Paul Silcocks, Elise Whitley, and Richard Doll
BMJ 2000 321: 323-329. [Abstract] [Full Text] [PDF]

Smoking reduction with oral nicotine inhalers: double blind, randomised clinical trial of efficacy and safety

Chris T Bolliger, Jean-Pierre Zellweger, Tobias Danielsson, Xandra van Biljon, Annik Robidou, Åke Westin, André P Perruchoud, and Urbain Säwe
BMJ 2000 321: 329-333. [Abstract] [Full Text] [PDF]

Regular review: Effectiveness of interventions to help people stop smoking: findings from the Cochrane Library

Tim Lancaster, Lindsay Stead, Chris Silagy, and Amanda Sowden
BMJ 2000 321: 355-358. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Thomas, J., Jones, G., Scarinci, I., Brantley, P. (2003). A Descriptive and Comparative Study of the Prevalence of Depressive and Anxiety Disorders in Low-Income Adults With Type 2 Diabetes and Other Chronic Illnesses. Diabetes Care 26: 2311-2317 [Abstract] [Full text]  
• Ho, J. C.-m., Zheng, S., Comhair, S. A. A., Farver, C., Erzurum, S. C. (2001). Differential Expression of Manganese Superoxide Dismutase and Catalase in Lung Cancer. Cancer Res. 61: 8578-8585 [Abstract] [Full text]  
• Davis, R. M (2000). Moving tobacco control beyond "the tipping point". BMJ 321: 309-310 [Full text]